MIAMI, FL – May 13, 2020 - Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients, announced today the Company has acquired the U.S. and Canadian rights to Ginger Tiger (www.gingertiger.net). Ginger Tiger was developed to help children and adults with special needs make their integration into society a more effective and joyful process. Ginger Tiger currently features more than 150 activities and looks to meet the challenge of students with special needs—roughly 7 million in the U.S. ages 3 to 21 being left with the need for education in the coronavirus pandemic (as recently cited in The Atlantic).
Students with disabilities often use assistive technology, which helps to increase their overall capacity to work, accomplish specific tasks, or participate in activities that otherwise might have been difficult or impossible. Many online platforms are not compatible with assistive technology, which leaves an underserved market for Ehave to serve.
For many special-education students, the tools that other children are using to make remote education possible—online platforms such as Zoom, Microsoft Teams and printed work packets—just aren’t accessible. Students with disabilities often use assistive technology; for instance, a student with visual impairments might use screen-reader software to have text read aloud, or a braille reader to read the text themselves. Many online platforms, however, are not compatible with assistive technology—and even when they are, other problems frequently arise.
According to the Special Education Expenditures Project, the total spending for students with disabilities amounted to $77.3 billion, or an average of $12,474 per student. Ginger Tiger is suitable for individuals of any age with specific learning disabilities, multiple disabilities, autism, physical disabilities, blindness and visual impairments, developmental delays, deafness and hearing impairments, mental delays, and speech and language impairments. Many education groups have endorsed fully funding the Individuals with Disabilities Education Act (IDEA), which underpins services for nearly 7 million students with disabilities. More federal funding for IDEA, which gets $13.6 billion in the current budget, would help special education programs, they say, but it would also more broadly affect all students as schools would no longer have to pull as much from their general education budgets. To be covered under IDEA, a child’s school performance must be “adversely affected” by a disability in one, or more, of the following 13 categories: Autism, Deaf-Blindness, Deafness, Developmental Delay, Emotional Disturbance, Hearing Impairment, Mental Retardation, Multiple Disabilities, Orthopedic Impairment, Other Health Impairment, Specific Learning Disability, Speech or Language Impairment, Traumatic Brain Injury, or Visual Impairment Including Blindness.
“The Ginger Tiger solution, when combined with our MegaTeam products, has the potential to serve a large number of the special needs student population who were left behind during this period of distanced learning," said Ben Kaplan, CEO of Ehave. "We are honored to be able to provide these E-learning tools to students, educators, and parents across the U.S. and Canada during the Coronavirus pandemic."
No one wants to have learning coming to a halt across America due to the COVID-19 outbreak and the U.S. Department of Education (Department) does not want to stand in the way of good faith efforts to educate students on-line (as outlined in a recent DOE Fact Sheet).
About Ehave, Inc.
Ehave, Inc. is a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients. Our primary focus is on improving the standard care in therapeutics to prevent or treat brain disorders or diseases through the use of digital therapeutics, psychedelics, independently or together, with medications, devices, and other therapies to optimize patient care and health outcomes meeting privacy and HIPAA & GDPR Compliant. Our main product is the Ehave Dashboard which is a mental health informatics platform that allows clinicians to make objective and intelligent decisions through data insight using Blockchain technology. The Ehave dashboard offers Offline Encrypted Digital Records Empowering Healthcare providers and patients and it's a powerful machine learning and artificial intelligence platform using artificial intelligence to extract deep insights from audio, video and text to improve research with a growing set of advanced tools and applications developed by Ehave and its leading partners. This empowers patients, healthcare providers, and payers to address a wide range of conditions through high quality, safe, and effective data-driven involvement with intelligent and accessible tools.
Forward-Looking Statement Disclaimer
This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Forward-looking statements are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements: (i) the initiation, timing, progress and results of the Company’s research, manufacturing and other development efforts; (ii) the Company’s ability to advance its products to successfully complete development and commercialization; (iii) the manufacturing, development, commercialization, and market acceptance of the Company’s products; (iv) the lack of sufficient funding to finance the product development and business operations; (v) competitive companies and technologies within the Company’s industry and introduction of competing products; (vi) the Company’s ability to establish and maintain corporate collaborations; (vii) loss of key management personnel; (viii) the scope of protection the Company is able to establish and maintain for intellectual property rights covering its products and its ability to operate its business without infringing the intellectual property rights of others; (ix) potential failure to comply with applicable health information privacy and security laws and other state and federal privacy and security laws; and (x) the difficulty of predicting actions of the USA FDA and its regulations. All forward-looking statements included in this press release are made only as of the date of this press release. The Company assumes no obligation to update any written or oral forward-looking statement unless required by law. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is contained under the heading "Risk Factors" in Ehave, Inc.’s Registration Statement on Form F-1 filed with the Securities and Exchange Commission (SEC) on September 24, 2015, as amended, which is available on the SEC's website, http://www.sec.gov.
